Quiz 1 Question 6 of 20

A technologist draws a Tc-99m sestamibi dose for a resting perfusion study. The vial label lists the drug name, activity, volume, and expiration time, and a tungsten syringe shield sits ready on the cart. Department policy requires the patient's identity and every label field checked against the order while the syringe stays shielded. Which verification and handling step must be completed before the syringe leaves the dosing area?

Select an answer to reveal the explanation.

Motivation